AMA, McKesson Enter Licensing Relationship to Track Molecular Diagnostic Testing

The American Medical Association and McKesson have announced that they have entered into a licensing relationship to offer healthcare systems a consistent way to identify and track molecular diagnostic tests.

Advertisement

The relationship between the two organizations will result in the creation of a new reference product that maps Z-Code Identifiers to Current Procedural Terminology (CPT) code sets. The AMA will use the information that laboratories and manufacturers submit and then share it in the McKesson Diagnostic Exchange to assign CPT code mappings where appropriate.

The new product will be available for licensing from the AMA early in 2014.  

More Articles on the American Medical Association:

AMA Foundation Honors Anesthesiologist Dr. Matthew Mandel for Volunteerism
AMA Names 2013 Excellence in Medicine Award Winners
5 Steps to Ensuring Hospital Data Security

Advertisement

Next Up in EHRs / Interoperability

Advertisement

Comments are closed.